The blood-brain barrier (BBB) does not exclusively refer to brain endothelial cells, which are the site of the barrier proper. In the past few years, it has become increasingly clear that BBB endothelial cells depend considerably on the brain microenvironment to a degree exceeding the environmental influence in other organs. The concept of the BBB has been continuously developed over the decades, culminating now in the recognition that endothelial cell function in the brain is not limited to simply mediating energy and oxygen transfer between blood and neural tissue. Endothelial cells are rather “Janus-headed beings” that are active partners of both luminal molecules and cells, as well as subendothelial cells such as pericytes, astrocytes, and neurons. In this overview, the authors present and discuss both the role of astroglial cells in managing the BBB and aspects of pathological alterations in the brain as far as the BBB is involved. After a brief introduction of the BBB that describes the structure and function of the brain capillary endothelial cells, the authors report on both the water channel protein aquaporin-4 (AQP4) in astrocytes and the extracellular matrix between astrocytes/pericytes and endothelial cells. The AQP4 has an important impact on the homeostasis in the brain parenchyma; however, the mechanistic cascade from the composition of the astrocyte membrane to the maintenance of BBB properties in the endothelial cells, including their tight junction formation, is still completely unknown.
Abbott NJ, Rönnbäck L., Hansson E.2006. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci7:41-53.
2.
Abramsson A., Kurup S., Busse M., Yamada S., Lindblom P., Schallmeiner E., and others.2007. Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development. Genes Dev21:316-31.
3.
Agrawal S., Anderson P., Durbeej M., Van Rooijen N., Ivars F., Opdenakker G., and others.2006. Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis . J Exp Med203:1007-19.
4.
Amiry-Moghaddam M., Ottersen OP2003. The molecular basis of water transport in the brain . Nat Rev Neurosci4:991-1001.
5.
Anfuso CD, Lupo G., Romeo L., Giurdanella G., Motta C., Pascale A., and others.2007. Endothelial cell-pericyte cocultures induce PLA2 protein expression through activation of PKCα and the MAPK/ERK cascade. J Lipid Res48:782-93.
Bandtlow CE, Zimmermann DR2000. Proteoglycans in the developing brain: new conceptual insights for old proteins. Physiol Rev80:1267-90.
8.
Barber AJ, Lieth E.1997. Agrin accumulates in the brain microvascular basal lamina during development of the blood-brain barrier. Dev Dyn208:62-74.
9.
Benfenati V., Nicchia GP, Svelto M., Rapisarda C., Frigeri A., Ferroni S.2007. Functional down-regulation of volume-regulated anion channels in AQP4 knockdown cultured rat cortical astrocytes. J Neurochem1000:87-104.
10.
Berzin TM, Zipser BD, Rafii MS, Kuo-Leblanc V., Yancopoulos GD, Glass DJ, and others.2000. Agrin and microvascular damage in Alzheimer's disease. Neurobiol Aging21:349-55.
11.
Bezakova G., Ruegg MA2003. New insights into the roles of agrin. Nature Rev Mol Cell Biol4:295-308.
12.
Blake DJ, Hawkes R., Benson MA, Beesley PW1999. Different dystrophin-like complexes are expressed in neurons and glia. J Cell Biol147:645-57.
13.
Blake DJ, Kröger S.2000. The neurobiology of Duchenne muscular dystrophy: learning lessons from muscle? Trends Neurosci23:92-9.
14.
Brightman MW, Reese TS1969. Junctions between intimately apposed cell membranes in the vertebrate brain. J Cell Biol40:648-77.
15.
Brillault J., Berezowski V., Cecchelli R., Dehouck MP2002. Intercommunications between brain capillary endothelial cells and glial cells increase the transcellular permeability of the BBB during ischemia. J Neurochem83:807-17.
16.
Bundgaard M., Abbott NJ2008. All vertebrates started out with a glial blood-brain barrier 4-500 million years ago. Glia56:699-708.
17.
Cattelino A., Liebner S., Zanetti A., Gallini R., Balconi G., Corsi A., and others.2003. The conditional inactivation of β-catenin gene in endothelial cells causes a defective vascular pattern and increased vascular fragility. J Cell Biol162:1111-22.
18.
Claude P.1978. Morphologic factors influencing transepithelial permeability: a model for the resistance of the zonula occludens. J Membr Biol39:219-32.
19.
Connors NC, Adams ME, Froehner SC, Kofuji P.2004. The potassium channel Kir4.1 associates with the dystrophin glycoprotein complex via alpha-syntrophin in glia. J Biol Chem279: 28387-92.
20.
Connors NC, Kofuji P.2002. Dystrophin Dp71 is critical for the clustered localization of potassium channels in retinal glial cells. J Neurosci22:4321-7.
21.
Coomber BL, Stewart PA1985. Morphometric analysis of CNS microvascular endothelium . Microvasc Res30:99-115.
22.
D'Atri F., Citi S.2002. Molecular complexity of vertebrate tight junctions. Mol Membr Biol19:103-12.
23.
Dejana E., Corada M., Lampugnani MG1995. Endothelial cell-to-cell junctions. FASEB J9:910-8.
Durbeej M., Henry MD, Campbell KP1998. Dystroglycan in development and disease. Curr Biol10:594-601.
26.
Dziegielewska KM, Ek J., Habgood MD, Saunders NR2001. Development of the choroid plexus. Microsc Res Tech52:5-20.
27.
Ebnet K.2008. Organization of multiprotein complexes at cell-cell junctions . Histochem Cell Biol130:1-20.
28.
Ehmsen J., Poon E., Davies K.2002. The dystrophin-associated protein complex. J Cell Sci115:2801-3.
29.
Ehrlich P.1885. Das Sauerstoff-Bedürfnis des Organismus. Eine farbenanalytische Studie. PhD diss., Herschwald, Berlin.
30.
Engelhardt B.2003. Development of the blood-brain barrier. Cell Tissue Res314:119-29.
31.
Folkman J., D'Amore PA1996. Blood vessel formation: what is its molecular basis ? Cell87:1153-5.
32.
Förster C.2008. Tight junctions and the modulation of barrier function in disease. Histochem Cell Biol130:55-70.
33.
Fredriksson L., Li H., Fieber C., Li X., Eriksson U.2004. Tissue plasminogen activator is a potent activator of PDGF-CC. EMBO J23:3793-802.
34.
Furuse M., Sasaki H., Tsukita S.1999. Manner of interaction of heterogenous claudin species within and between tight junction strands. J Cell Biol147:891-903.
35.
Gee SH, Montanaro F., Lindenbaum MH, Carbonetto S.1994. Dystroglycan-α: a dystrophin-associated glyoprotein, is a functional agrin receptor. Cell77:675-86.
González-Mariscal L., Betanzos A., Nava P., Jaramillo BE2003. Tight junction proteins. Progr Biophys Mol Biol81:1-44.
38.
Guadagno E., Moukhles H.2004. Laminin-induced aggregation of the inwardly rectifying potassium channel, Kir4.1, and the water-permeable channel, AQP4, via a dystroglycan-containing complex in astrocytes. Glia47:138-49.
39.
Guo M., Cox B., Mahale S., Davis W., Carranza A., Hayes K., and others.2008. Pre-ischemic exercise reduces matrix metalloproteinase-9 expression and ameliorates blood-brain barrier dysfunction in stroke. Neuroscience151:340-51.
40.
Gurney KJ, Estrada EY, Rosenberg GA2006. Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation. Neurobiol Dis23:87-96.
41.
Haenggi T., Soontornmalai A., Schaub MC, Fritschy J-M.2004. The role of utrophin and Dp71 for assembly of different dystrophin-associated protein complexes (DPCs) in the choroid plexus and microvasculature of the brain. Neuroscience129:403-13.
42.
Hallmann R., Horn N., Selg M., Wendler O., Pausch F., Sorokin LM2005. Expression and function of laminins in the embryonic and mature vasculature. Physiol Rev85:979-1000.
43.
Haorah J., Ramirez SH, Schall K., Smith D., Pandya R., Persidsky Y.2007a. Oxidative stress activates protein tyrosine kinase and matrix metalloptroteinases leading to blood-brain barrier dysfunction . J Neurochem101:566-76.
44.
Haorah J., Schall K., Ramirez SH, Persidsky Y.2007b. Activation of protein tyrosine kinases and matrix metalloproteinases causes blood-brain barrier injury: novel mechanism for neurodegeneration associated with alcohol abuse. Glia56:78-88.
45.
Heiskala M., Peterson PA, Yang Y.2001. The roles of claudin superfamily proteins in paracellular transport. Traffic2:92-8.
46.
Hellström M., Gerhardt H., Kalén M., Li X., Eriksson U., Wolburg H., and others.2001. Lack of pericytes leads to endothelial hyperplasia and abnormal morphogenesis . J Cell Biol153:543-53.
47.
Holt KH, Crosbie RH, Venzke DP, Campbell KP2000. Biosynthesis of dystroglycan: processing of a precursor propeptide. FEBS Lett468:79-83.
48.
Huber JD, Egleton RD, Davis TP2001. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci24:719-25.
49.
Iadecola C.2004. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci5:347-60.
50.
Kanesaka T., Mori M., Hattori T., Oki T., Kuwabara S.2006. Serum matrix metalloproteinase-3 levels correlate with disease activity in relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatr77:185-8.
51.
Kim GW, Lewén A., Copin J.-C, Watson BD, Chan PH2001. The cytosolic antioxidant, copper/zinc superoxide dismutase, attenuates blood-brain barrier disruption and oxidative cellular injury after photothrombotic cortical ischemia in mice. Neuroscience105:1007-18.
52.
Kniesel U., Risau W., Wolburg H.1996. Development of blood-brain barrier tight junctions in the rat cortex. Dev Brain Res96:229-40.
53.
Kofuji P., Ceelen P., Zahs KR, Surbeck LW, Lester HA, Newman EA2000. Genetic inactivation of an inwardly rectifying potassium channel (Kir4.1 subunit) in mice: phenotypic impact in retina. J Neurosci20:5733-40.
54.
Kröger S., Schröder JE2002. Agrin in the developing CNS: new roles for a synapse organizer . News Physiol Sci17:207-12.
55.
Lagrange P., Romero IA, Minn A., Revest PA1999. Trans-endothelial permeability changes induced by free radicals in an in vitro model of the blood-brain barrier. Free Radic Biol Med27:667-72.
56.
Lai C.-H., Kuo K.-H.2005. The critical component to establish in vitro BBB model: pericyte. Brain Res Rev50:258-65.
57.
Lidov HG, Byers TJ, Kunkel LM1993. The distribution of dystrophin in the murine central nervous system: an immunocytochemical study. Neuroscience54:167-87.
58.
Liebner S., Corada M., Bangsow T., Babbage J., Taddei A., Czupalla CJ, and others.2008. Wnt/β-catenin signalling controls development and maintenance of the blood-brain barrier. J Cell Biol183:409-17.
59.
Liebner S., Engelhardt B.2005. Development of the blood-brain barrier. In: DeVries E, Prat A , editors. The blood-brain barrier and its microenvironment: basic physiology to neurological disease. New York: Taylor & Francis. p 1-25.
60.
Liebner S., Fischmann A., Rascher G., Duffner F., Grote E-H., Kalbacher H., and others. 2000. Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathol100:323-31.
61.
Lindahl P., Johansson BR, Leveen P., Betsholtz C.1997. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science277:242-5.
62.
Lindblom P., Gerhardt G., Liebner S., Abramsson A., Enge M., Hellström M., and others.2003. Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev17:1835-40.
63.
Martinez-Palomo A., Meza I., Beaty G., Cereijido M.1980. Experimental modulation of occluding junctions in a cultured transporting epithelium. J Cell Biol87:736-45.
64.
Matter K., Balda MS2003. Signalling to and from tight junctions. Nat Rev Mol Biol4:225-36.
65.
McMahan UJ1990. The agrin hypothesis. Cold Spring Harb Symp Quant Biol55:407-18.
66.
Milner R., Hung S., Wang X., Spatz M., Del Zoppo GJ2008. The rapid decrease in astrocyte-associated dystroglycan expression by focal cerebral ischemia is protease-dependent. J Cerebr Blood Flow Metab28:812-23.
67.
Møllgard K., Malinowska DH, Saunders NR1980. Lack of correlation between tight junction morphology and permeability properties in the choroid plexus. Nature264:293-4.
68.
Moore SA, Saito F., Chen J., Michele DE, Henry MD, Messing A., and others.2002. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature418:422-5.
69.
Morita K., Sasaki H., Furuse M., Tsukita S.1999. Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J Cell Biol147:185-94.
70.
Mulligan SJ, MacVicar BA2004. Calcium transients in astrocyte endfeet cause cerebrovascular constrictions. Nature431:195-9.
71.
Nagelhus EA, Mathisen TM, Ottersen OP2004. Aquaporin-4 in the central nervous system: cellular and subcellular distribution and coexpression with Kir4.1. Neuroscience129:905-13.
72.
Nagy Z., Peters H., Hüttner I.1984. Fracture faces of cell junctions in cerebral endothelium during normal and hyperosmotic conditions. Lab Invest50:313-22.
73.
Nakagawa S., Deli MA, Nakao S., Honda M., Hayashi K., Nakaoke R., and others.2007. Pericytes from brain microvessels strengthen the barrier integrity in primary cultures of rat brain endothelial cells. Cell Mol Neurobiol27:687-94.
74.
Neely JD, Amiry-Moghaddam M., Ottersen OP, Froehner SC, Agre P., Adams ME2001. Syntrophin-dependent expression and localization of aquaporin-4 water channel protein. Proc Natl Acad Sci USA98:14108-13.
75.
Neuhaus J.1990. Orthogonal arrays of particles in astroglial cells: quantitative analysis of their density, size, and correlation with intramembranous particles . Glia3:241-51.
76.
Nicchia GP, Nico B., Camassa LMA, Mola MG, Loh N., Dermietzel R., and others. 2004. The role of aquaporin-4 in the blood-brain barrier development and integrity: studies in animal and cell culture models . Neuroscience129:935-45.
77.
Nico B., Frigeri A., Nicchia GP, Quondamatteo F., Herken R., Errede M., and others. 2001. Role of aquaporin-4 water channel in the development and integrity of the blood-brain barrier. J Cell Sci114:1297-307.
78.
Nico B., Nicchia GP, Frigeri A., Corsi P., Mangieri D., Ribatti D., and others. 2004. Altered blood-brain barrier development in dystrophic mdx mice. Neuroscience125:921-35.
79.
Nielsen S., Nagelhus EA, Amiry-Moghaddam M., Bourque C., Agre P., Ottersen OP1997. Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain . J Neurosci17:171-80.
80.
Nitkin RM, Smith MA, Magill C., Fallon JR, Yao Y-MM, Wallace BG, and others. 1987. Identification of agrin, a synaptic organizing protein from Torpedo electric organ. J Cell Biol105:2471-8.
81.
Nitta T., Hata M., Gotoh S., Seo Y., Sasaki H., Hashimoto N., and others. 2003. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol161:653-60.
82.
Noell S., Fallier-Becker P., Beyer C., Kröger S., Mack AF, Wolburg H.2007. Effects of agrin on the expression and distribution of the water channel protein aquaporin-4 and volume regulation in cultured astrocytes . Eur J Neurosci26:2109-18.
83.
Papadopoulos MC, Krishna S., Verkman AS2002. Aquaporin water channels and brain edema. Mount Sinai J Med69:242-8.
84.
Peppiat CM, Howarth C., Mobbs P., Attwell D.2007. Birectional control of CNS capillary diameter by pericytes . Nature443:700-4.
85.
Peters A., Palay SL, Webster H.1991. The fine structure of the nervous system. New York: Oxford University Press.
86.
Piontek J., Winkler L., Wolburg H., Müller SL, Zuleger N., Piehl C., and others. 2008. Formation of tight junction: determinants of homophilic interaction between classic claudins. FASEB J22:146-58.
87.
Ransohoff RM, Kivisääk P., Kidd G.2003. Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol3:569-81.
88.
Rascher G., Fischmann A., Kröger S., Duffner F., Grote E.-H, Wolburg H.2002. Extracellular matrix and the blood-brain barrier in glioblastoma multiforme: spatial segregation of tenascin and agrin. Acta Neuropathologica104:85-91.
89.
Rascher-Eggstein G., Liebner S., Wolburg H.2004. The blood-brain barrier in the human glioma. In: Sharma HS, Westman J , editors. Blood-spinal cord and brain barriers in health and disease. Amsterdam: Elsevier . p 561-76.
90.
Rash JE, Yasumura T., Hudson CS, Agre P., Nielsen S.1998. Direct immunogold labeling of aquaporin-4 in square arrays of astrocyte and ependymocyte plasma membranes in rat brain and spinal cord . Proc Natl Acad Sci USA95:11981-6.
91.
Reese TS, Karnovsky MJ1967. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol34:207-17.
92.
Risau W., Hallmann R., Albrecht U.1986. Differentiation-dependent expression of protein in brain endothelium during development of the blood-brain barrier. Dev Biol117:537-45.
93.
Rosenberg GA2005. Matrix metalloproteinases and proteolytic opening of the blood-brain barrier in neuroinflammation. In: De Vries E, Prat A, editors. The blood-brain barrier and its microenvironment: basic physiology to neurological disease. New York: Taylor & Francis. p 335-8.
94.
Rosenberg GA, Navratil M., Barone F., Feuerstein G.1996. Proteolytic cascade enzyme increase in focal cerebral ischemia in rat. J Cerebr Blood Flow Metab16:360-6.
95.
Ruiz-Ederra J., Zhang H., Verkman AS2007. Evidence against functional interaction between aquaporin-4 water channels and Kir4.1 potassium channels in retinal Müller cells. J Biol Chem282:21866-72.
96.
Saadoun S., Papadopoulos MC, Davies DC, Krishna S., Bell BA2002. Aquaporin-4 expression is increased in oedematous human brain tumors. J Neurol Neurosurg Psychiatry72:262-5.
97.
Saunders NR, Ek J., Habgood MD, Dziegielewska KM2008. Barriers in the brain: a renaissance? Trends Neurosci31:279-86.
98.
Saunders NR, Knott GW, Dziegielewska KM2000. Barriers in the immature brain. Cell Mol Neurobiol20:29-40.
99.
Schreibelt G., Kooij G., Reijerkerk A., Van Doorn R., Gringhuis SI, Van der Pol S., and others. 2007a. Reactive oxygen species alter endothelial tight junction dynamics via rhoA, PI3 kinase, and PKB signalling. FASEB J 21:3666-76.
100.
Schreibelt G., Van Horssen J., Van Rossum S., Dijkstra CD, Drukarch B., De Vries HE2007b. Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology. Brain Res Rev56:322-30.
101.
Schulze C., Firth JA1993. Immunohistochemical localization of adherens junction components in blood-brain barrier microvessels of the rat. J Cell Sci104:773-82.
102.
Simard M., Nedergaard M.2004. The neurobiology of glia in the context of water and ion homeostasis. Neuroscience129:877-96.
103.
Sixt M., Engelhardt B., Pausch F., Hallmann R., Wendler O., Sorokin LM2001. Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis. J Cell Biol153:933-46.
104.
Smith MA, Hilgenberg LGW.2002. Agrin in the CNS: a protein in search of a function ? NeuroReport13:1485-95.
105.
Solé S., Petegnief V., Gorina R., Chamorro Á., Planas AM2004. Activation of matrix metalloproteinase-3 and agrin cleavage in cerebral ischemia/reperfusion. J Neuropathol Exp Neurol63:338-49.
106.
Staehelin LA1974. Structure and function of intercellular junctions . Int Rev Cytol39:191-283.
107.
Stewart PA, Wiley MJ1981. Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: a study using quail-chick transplantation chimeras. Dev Biol84:183-92.
108.
Su EJ, Fredriksson L., Geyer M., Folestad E., Cale J., Andrae J., and others. 2008. Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nature Med14:731-7.
109.
Takano T., Tian G.-F, Peng W., Lou N., Libionka W., Han X., and others. 2006. Astrocyte-mediated control of cerebral blood flow. Nature Neurosci9:260-7.
110.
Tian M., Jacobsen C., Gee SH, Campbell KP, Carbonetto S., Jucker M.1996. Dystroglycan in the cerebellum is a laminin α2 chain binding protein at the glial-vascular interface and is expressed in Purkinje cells. Eur J Neurosci8:2739-47.
111.
Tsukita S., Furuse M., Itoh M.2001. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol2:285-93.
112.
Ueda H., Baba T., Kashiwagi K., Iijima H., Ohno S.2000a. Dystrobrevin localization in photoreceptor axon terminals and at blood-ocular barrier sites. Invest Ophthalmol Vis Sci41:3908-14.
113.
Ueda H., Baba T., Terada N., Kato Y., Fuji Y., Takayama I., and others. 2000b. Immunolocalization of dystrobrevin in the astrocytic endfeet and endothelial cells in the rat cerebellum. Neurosci Lett283:121-4.
114.
Usatyuk PV, Parinandi NL, Natarajan V.2006. Redox regulation of 4-hydroxy-2-nonenal-mediated endothelial barrier dysfunction by focal adhesion, adherens, and tight junction proteins . J Biol Chem281:35554-66.
115.
van Itallie CM, Anderson JM2006. Claudins and epithelial paracellular transport . Annu Rev Physiol68:403-29.
116.
VanSaun M., Werle MJ2000. Matrix metalloproteinase-3 removes agrin from synaptic basal lamina. J Neurobiol43:140-9.
117.
Verbavatz J-M., Ma T., Gobin R., Verkman AS1997. Absence of orthogonal arrays in kidney, brain and muscle from transgenic knockout mice lacking water channel aquaporin-4. J Cell Sci110:2855-60.
118.
Virgintino D., Girolamo F., Errede M., Capobianco C., Robertson D., Stallcup WB, and others. 2007. An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis . Angiogenesis10:35-45.
119.
Wakai S., Hirokawa N.1978. Development of the blood-brain barrier to horseradish peroxidase in the chick embryo. Cell Tissue Res195:195-203.
120.
Warth A., Kröger S., Wolburg H.2004. Redistribution of aquaporin-4 in human glioblastoma correlates with loss of agrin immunoreactivity from brain capillary basal laminae. Acta Neuropathol107:311-8.
121.
Warth A., Mittelbronn M., Wolburg H.2005. Redistribution of the water channel protein aquaporin-4 and the K+ channel protein Kir4.1 differs in low- and high-grade human brain tumors. Acta Neuropathol109:418-26.
122.
Winder SJ2001. The complexities of dystroglycan. Trends Biochem Sci26:118-24.
123.
Wolburg H.1995. Orthogonal arrays of intramembranous particles: a review with special reference to astrocytes. J Brain Res36:239-58.
124.
Wolburg H.2006. The endothelial frontier. In: Dermietzel R, Spray DC , Nedergaard M, editors. Blood-brain barriers: from ontogeny to artificial interfaces. Weinheim: Wiley-VCH. p 7-107.
125.
Wolburg H., Lippoldt A.2002. Tight junctions of the blood-brain barrier: development, composition and regulation. Vasc Pharmacol38:323-37.
126.
Wolburg H., Lippoldt A., Ebnet K.2006. Tight junctions and the blood-brain barrier. In: Gonzales-Mariscal L, editor. Tight Junctions . New York: Springer Science. p 175-95.
127.
Wolburg H., Neuhaus J., Kniesel U., Krauss B., Schmid E-M., Öcalan M., and others. 1994. Modulation of tight junction structure in blood-brain barrier endothelial cells: effects of tissue culture, second messengers and cocultured astrocytes. J Cell Sci107:1347-57.
128.
Wolburg H., Wolburg-Buchholz K., Kraus J., Rascher-Eggstein G., Liebner S., Hamm S., and others. 2003. Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme. Acta Neuropathol105:586-92.
129.
Yang B., Brown D., Verkman AS1996. The mercurial insensitive water channel (AQP-4) forms orthogonal arrays in stably transfected chinese hamster ovary cells . J Biol Chem271:4577-80.
130.
Yang Y., Estrada EY, Thompson JF, Liu W., Rosenberg GA2007. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cerebr Blood Flow Metab27:698-709.
131.
Yepes M., Sandkvist M., Moore EG, Bugge TH, Strickland DK, Lawrence DA2003. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J Clin Invest112:1533-40.
132.
Zlokovic BV2008. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron57:178-201.
133.
Zozulya A., Weidenfeller C., Galla H-G.2008. Pericyte-endothelial cell interaction increases MMP-9 secretion at the blood-brain barrier in vitro. Brain Res1189:1-11.
